Pharmacokinetics of WILATE and Haemate P in von Willebrand type 3 patients - a prospective, randomised, controlled, open-labelled, 2-arm cross-over study
Latest Information Update: 03 Mar 2017
At a glance
- Drugs Factor VIII/von Willebrand factor (Primary)
- Indications Von Willebrand disease
- Focus Pharmacokinetics
- Sponsors Octapharma
- 03 Mar 2017 New trial record